nivolumab,ipilimumab
bms
['nivo', 'renal,(-adrenal)']
characterizing progression to subsequent lines of therapy in metastatic #renalcellcarcinoma after nivo+ipi: results from the imdc. presentation by audreylie lemelin, md . #asco23 written coverage by &gt; 
Largest global online community of #urological medical professionals & patients. #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology